PharmEasy to pick up 66.1% stake in Thyrocare for Rs 4,546 crore

The combined entity will have the ability to provide diagnostics and pharmacy services to 100 million-plus Indians within 24 hours, the company said in a statement

Online medicine delivery firm PharmEasy on Friday announced that its parent API Holdings Ltd (API) will acquire 66.1 per cent stake in Thyrocare for Rs 4,546 crore from Dr A Velumani and affiliates.

Thyrocare is the largest B2B player in the diagnostics space and has a network  of  3,330+ collection centres across in 2,000+ towns in India.

On  the  addition  of  Thyrocare  into  its  portfolio,  Mr  Siddharth  Shah,  CEO,  API Holdings said: “We are delighted to be partnering Thyrocare. We will provide world class customer experience  in  diagnostics,  rivalling  our  pharmacy  experience  by  leveraging  technology,  and building on top of